Appeals Court Revives Lawsuits Tying Tylenol Use in Pregnancy to Autism and A.D.H.D.
Azeen Ghorayshi / nytimes - A federal appeals court overruled a district court judge who dismissed the lawsuits, citing unreliable scientific evidence.
AI Summary: An appeals court has revived private lawsuits claiming prenatal acetaminophen exposure is linked to neurodevelopmental disorders such as autism and ADHD, sending scores of cases back into litigation. Plaintiffs allege longstanding product liability and causation questions that will now play out in courtrooms rather than headlines. Legal battles, not medical consensus, will determine next steps.
Two tests GPs can soon offer to help spot endometriosis
bbc - Experts hope they will be a game-changer and cut the nine-year or longer diagnosis waits patients can currently face.
AI Summary: Emerging research on hormonal signatures and blood biomarkers has led to development of tests GPs may soon use to spot endometriosis earlier. Patient accounts underline the life‑changing potential of timely diagnosis. The work promises less guesswork, fewer invasive procedures, and fewer years lost to unexplained pain—so yes, medicine might actually make life convenient for once.
Meningococcal B vaccine ineffective in gonorrhea prevention for men who have sex with men
medicalxpress - The meningococcal B vaccine is ineffective in gonorrhea prevention among men who have sex with men (MSM) at high risk of infection, according to findings from the world's largest randomized controlled trial (RCT) into possible efficacy published in the Ne…
AI Summary: A major study found that the meningococcal B (MenB) vaccine does not provide protection against gonorrhea in men who have sex with men, contradicting earlier hopes that cross-protection might exist. Researchers emphasize the need for dedicated gonorrhea vaccines and continued public-health measures to control rising infection rates.
Ovarian Function Suppression Plus Tamoxifen Significantly Reduces Premenopausal Breast Cancer Recurrence Over Tamoxifen and Further Reduction Is Seen When Combined with Exemestane
esmo - Findings from the SOFT and TEXT studies
AI Summary: A new analysis shows adding ovarian function suppression to tamoxifen substantially lowers recurrence in premenopausal breast cancer patients compared with tamoxifen alone, with even greater reduction when switched to exemestane. Clinicians should note the clear endocrine benefit — and patients can sigh with cautious optimism while weighing menopausal side effects.
First use of precision editing to study human embryo development reveals role of master gene
medicalxpress - Research led by the University of Cambridge Loke Center for Trophoblast Research has shown that a genome-editing technique can be used to alter a single gene in human embryonic cells, enabling the study of very early human development in unparalleled deta…
AI Summary: Scientists used precision genome editing in human embryos to identify a 'master' developmental gene that triggers early human development stages. The finding clarifies key molecular steps, offering insights into congenital disorders and embryology, but also reignites ethical debate over experimental editing — cue the lab‑coat philosophers.
A Ban Won’t Stop Abortion Pill Access, Telehealth Providers Say
Kate Wells / kffhealthnews - As a federal court mulls a case that could result in significant restrictions on a pill used in most abortions, providers say they have alternatives to preserve access even in states with bans in place.
AI Summary: Providers and telehealth advocates warn that banning access won’t stop patients from obtaining abortion pills online. Telemedicine and pharmacy workarounds continue to provide routes for care, underscoring limits of state bans and foreshadowing prolonged legal and practical battles over remote prescribing, cross‑border services, and patient privacy.
Deep learning–enabled discovery of antibiotics effective against Neisseria gonorrhoeae
Melis N. Anahtar, Jacqueline A. Valeri, Seyed Majed Modaresi, Aarti Krishnan, Nina M. Donghia, Saman / science - Science Translational Medicine, Volume 18, Issue 854, June 2026.
AI Summary: Researchers used deep‑learning screening of millions of compounds to identify two promising leads active against drug‑resistant Neisseria gonorrhoeae. The AI‑driven approach accelerated hit discovery and produced chemical scaffolds now entering preclinical follow‑up, offering a potential new avenue in an area desperate for novel antibiotics.
Cervical cancer deaths have plummeted thanks to HPV vaccine
newscientist - We already know the vaccine against human papillomavirus, or HPV, greatly reduces infections and cases of cervical cancer, and now we have the first evidence it prevents deaths too
AI Summary: New population data show the HPV vaccination program has driven a sharp drop in cervical cancer mortality, effectively eliminating deaths among the youngest women in reported cohorts. The findings underscore vaccine impact on prevention, bolster calls for broader uptake, and highlight a rare public‑health victory that actually lives up to the hype.
- England study: near-zero deaths in vaccinated young women (9)
- Scaling vaccines and screening: global equity and strategies (5)
England study: near-zero deaths in vaccinated young women
Scaling vaccines and screening: global equity and strategies
NRG-GY018 at ASCO 2026: Pembrolizumab Plus Chemotherapy Sustains Overall Survival Benefit in Advanced Endometrial Cancer
oncodaily - The NRG-GY018 trial returned to the ASCO 2026 stage with the question that matters more than any progression endpoint: do patients actually live longer? Presented by Ramez N. Eskander, MD […]
AI Summary: Updated results from the NRG‑GY018 trial show adding pembrolizumab to chemotherapy sustains an overall survival benefit in advanced endometrial cancer. The follow‑up confirms the durability of immunotherapy’s impact and supports integrating checkpoint inhibitors into standard regimens for eligible patients, potentially changing practice for a cancer type that’s long hungered for better systemic options.
Short-term fasting could boost chemo response in ovarian cancer, study suggests
medicalxpress - A simple change in meal timing may help improve outcomes for women with the most common and aggressive form of ovarian cancer, a new study suggests.
AI Summary: ASCO‑presented research indicates short‑term fasting around chemotherapy cycles can enhance response in high‑grade serous ovarian cancer versus a regular diet, altering tumor biology to increase chemosensitivity. The findings suggest a low‑cost adjunct to standard treatment, though real‑world feasibility and longer‑term benefits require larger trials — fasting as a potential therapeutic booster, not a fad.
Curtis Henry: Impact of Weight Loss Drugs on Immune Responses and Anti-Tumor Immunity
oncodaily - Curtis Henry, shared a post on LinkedIn: “I just want to give a huge nod to Claire Pillsbury, a postdoctoral fellow in my laboratory, conducting research on how weight loss […]
AI Summary: Health authorities have put forward proposed plans for Liverpool Women’s Hospital outlining redevelopment and service reconfiguration intended to modernize maternity and women's services. Officials are seeking public feedback while the community and clinicians press for clarity on capacity, timelines and funding — because nothing says progress like blueprints that invite polite panic.
Genital herpes rising in England, despite overall drop in STIs
bbc - STIs are particularly common among young people, with health experts saying testing for them is vital.
AI Summary: Public-health surveillance shows genital herpes cases climbing in England even as many other sexually transmitted infections fall. Experts warn the uptick signals gaps in prevention, testing and sexual-health services, underscoring the need for better awareness and targeted care rather than assuming the problem will fix itself. Yes, herpes is back on the agenda.
In a First, Scientists Precisely Edit Human Embryo Genes
Carl Zimmer / nytimes - Researchers relied on a newer gene-editing technique that may make it possibl to engineer embryos, a prospect that has long alarmed bioethicists.
AI Summary: Researchers report the first precise edits to human embryo genes, demonstrating a technical milestone that immediately reopened the ethical and safety conversation about germline modification. Scientists urge caution, tighter oversight and more study before any clinical application while bioethicists debate whether we’ve crossed a line that’s been long teased in science fiction.
Not just ovaries—new name for PCOS reflects the condition's multisystem nature
medicalxpress - An estimated 1 in 8 women live with polycystic ovarian syndrome, commonly referred to as PCOS. However, the name is a bit of a misnomer; it suggests that the condition affects only the ovaries. In actuality, the condition is a broader metabolic and hormon…
AI Summary: Medical experts announced a name change for polycystic ovary syndrome to better reflect its multisystem effects rather than framing it solely as an ovarian disorder. The update aims to reduce stigma, encourage holistic management of metabolic and psychological comorbidities, and align terminology with current scientific understanding of the condition.
Kicking Off the Cancer Planners Forum in Geneva – UICC
oncodaily - Union for International Cancer Control (UICC) shared a post on LinkedIn: “We’re excited to kick off the Cancer Planners Forum in Geneva today! Convening national leaders responsible for cancer control planning, […]
AI Summary: The UICC Cancer Planners Forum in Geneva brought policymakers, clinicians, and public‑health leaders together to map national cancer control strategies, prioritize cervical cancer elimination, and foster implementation partnerships. The forum emphasized practical planning, stakeholder engagement, and resource‑sensitive solutions to turn plans into measurable improvements in prevention, screening, and care delivery.
- Cervical cancer elimination and clinical partnerships (3)
- Forum launch and wrap-up in Geneva (3)
- National cancer planning and policy priorities (3)
- All Other Stories
Cervical cancer elimination and clinical partnerships
Forum launch and wrap-up in Geneva
National cancer planning and policy priorities
All Other Stories
Women’s experiences are forgotten in research on childbirth and breastfeeding
Thomas Saïas, Professeur de psychologie, Université du Québec à Montréal (UQAM) / theconversation - Two studies in the field of perinatal care show how, in the areas of breastfeeding and obstetrics, science prioritizes risk and the baby at the expense of mothers’ well-being.
AI Summary: New analyses show that research into childbirth and breastfeeding repeatedly sidelines women's firsthand experiences, prioritizing clinical metrics over lived realities. Experts warn this gap limits understanding of postpartum challenges, skews policy and perpetuates poorer care. Calls are growing for qualitative measures, patient-centered outcomes and inclusive study designs that actually listen to mothers.
- Clinical and policy focus on fetus over mothers' care (3)
- Mothers’ experiences ignored in childbirth and breastfeeding research (4)
- Women’s pain and reproductive conditions dismissed by medicine (4)
- All Other Stories
Clinical and policy focus on fetus over mothers' care
Mothers’ experiences ignored in childbirth and breastfeeding research
Women’s pain and reproductive conditions dismissed by medicine
All Other Stories
License to deliver: Some midwives break the law to assist with home births
medicalxpress - In a midwife's suburban Atlanta home with a playground and chicken coop outside, Madie Collins lay on an examination table while the midwife measured her pregnant belly. Unlike at many a doctor's office, no crinkly paper sheet covered the table and no ant…
AI Summary: A growing number of midwives are reportedly supporting planned home births outside legal frameworks, knowingly operating without required licences. Regulators and health systems face a tricky balance between enforcing safety standards and meeting demand for community-based birthing options. Expect investigations, heated debates, and at least one bureaucrat suddenly very busy.
Supreme Court preserves access to abortion pill by mail
Sydney Halleman / healthcaredive - The ruling maintains access to mifepristone while litigation continues. The drug can still be prescribed at pharmacies or by mail without requiring in-person visits.
AI Summary: The Supreme Court intervened to maintain access to mifepristone, temporarily restoring telehealth prescribing and preserving mail distribution while litigation proceeds. The decision keeps the pill available nationwide, blocking lower-court restrictions that would have sharply limited remote access and complicated routine clinical care for patients and providers.
PCOS has been officially renamed PMOS, and it’s a momentous move
newscientist - PCOS will now be known as PMOS (polyendocrine metabolic ovarian syndrome), and for Alice Klein, who has the conditon, it's been a long time coming
AI Summary: Medical experts have rebranded polycystic ovary syndrome as "polyendocrine metabolic ovarian syndrome" (PMOS) to better reflect its metabolic and endocrine drivers and improve diagnosis and treatment for about 170 million affected women worldwide. The change follows years of debate over an inaccurate name and aims to reduce misdiagnosis and guide more targeted care—because calling it something sensible might actually help.
Court restricts abortion access across US by blocking mailing of mifepristone
abcnews - A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone
AI Summary: A federal appeals court has imposed new limits on distribution of mifepristone, blocking mail-order shipments and narrowing telehealth-based prescribing. The decision immediately complicates access for patients and clinicians who rely on remote care and pharmacy delivery, forcing last‑minute logistical changes, increased travel, and swift legal and policy responses as providers scramble to adapt.
- Appeals court halts mail and telehealth access (4)
- Clinical pivots and drug alternatives amid disruptions (3)
- Supreme Court temporarily restores mail access (5)
- All Other Stories